Picture of THERAGEN ETEX CO logo

066700 THERAGEN ETEX CO Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareBalancedSmall CapContrarian

Annual cashflow statement for THERAGEN ETEX CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsARSARSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11,38510,95128,392-39,28111,746
Depreciation
Amortisation
Non-Cash Items10,634-134-13,97152,616897
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-251-6,315-8,140-17,643-8,147
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities4,0079,59312,1251,78810,972
Capital Expenditures-2,749-4,193-4,797-11,392-2,576
Purchase of Fixed Assets
Other Investing Cash Flow Items-1746,068-8,982-2,624163
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-2,9241,875-13,779-14,016-2,413
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3,103-5,2765,09112,5594,604
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2,1096,1163,41247313,149